Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 8.362\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a CCOc1ccc(CCNC(=O)CCNC(=O)c2ccc(Br)cc2)cc1OCC
b CC1(C)CC2(CCO1)C(Nc1ccccc1)=NC(=S)N2CC(N)=O
c C=CCN(CC=C)CCCOc1ccccc1C(=O)OC.O=C(O)C(=O)O
d COc1ccc(N2CCN(C(=O)CSc3nnc4n3C(C)(C)Cc3ccccc3-4)CC2)cc1
e O=S(=O)(NC1CCCC1)c1cccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)c1
Answer: a. CCOc1ccc(CCNC(=O)CCNC(=O)c2ccc(Br)cc2)cc1OCC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(CCNC(=O)CCNC(=O)c2ccc(Br)cc2)cc1OCC
CCOc1ccc(CCNC(=O)CCNC(=O)c2ccc(Br)cc2)cc1OCC
4-bromo-N-[3-oxo-3-[2-(4,5-diethoxyphenyl)ethylamino]propyl]benzamide